أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - vancomycin hydrochloride, quantity: 476 mg (equivalent: vancomycin, qty 500000 iu) - injection, powder for - excipient ingredients: hydrochloric acid; sodium hydroxide - vancomycin juno is indicated in potentially life-threatening infections which cannot be treated with another effective, less toxic antimicrobial drug, including the penicillins and cephalosporins.,vancomycin juno is useful in therapy of severe staphylococcal (including methicillin-resistant staphylococcal) infections in patients who cannot receive or who failed to respond to the penicillins and cephalosporins or who have infections with staphylococci that are resistant to other antibiotics. once sensitivity data are available, therapy should be adjusted accordingly.,vancomycin juno is effective alone or in combination with an aminoglycoside for endocarditis caused by s. viridans or s. bovis. for endocarditis caused by enterococci (e.g. e. faecalis), vancomycin juno is effective only in combination with an aminoglycoside. vancomycin juno is effective for the treatment of diphtheroid endocarditis. vancomycin juno is used in combination with rifampin, an aminoglycoside, or both in early-onset prosthetic valve endocarditis caused by s. epidermidis or diphtheroids.,the effectiveness of vancomycin juno has been documented in other infections due to staphylococci including osteomyelitis, pneumonia, septicaemia, and soft tissue infections. when staphylococcal infections are localised and purulent, antibiotics are used as adjuncts to appropriate surgical measures.,specimens for bacteriologic cultures should be obtained in order to isolate and identify causative organisms and to determine their susceptibilities to vancomycin juno.,vancomycin juno should be administered orally for the treatment of staphylococcal enterocolitis and antibiotic associated pseudomembranous colitis produced by c. difficile. parenteral administration of vancomycin juno alone is inappropriate for this indication. vancomycin is not effective by the oral route for other types of infections. for oral administration the parenteral formulation may be used. some systemic absorption may occur following oral administration in patients with pseudomembranous colitis.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - vancomycin hydrochloride, quantity: 1025 mg (equivalent: vancomycin, qty 1000 mg) - injection, powder for - excipient ingredients: hydrochloric acid; sodium hydroxide - vancomycin hydrochloride for intravenous infusion is indicated for potentially life threatening infections which cannot be treated with another effective, less toxic antimicrobial medicine, including the penicillins and cephalosporins. vancomycin is useful in therapy of severe staphylococcal (including methicillin-resistant staphylococcal) infections in patients who cannot receive or who have failed to respond to the penicillins and cephalosporins or who have infections with staphylococci that are resistant to other antibiotics. once sensitivity data are available, therapy should be adjusted accordingly. vancomycin is effective alone or in combination with an aminoglycoside for endocarditis caused by strep. viridans or strep. bovis. for endocarditis caused by enterococci (eg enterococcus faecalis), vancomycin is effective only in combination with an aminoglycoside. vancomycin is effective for the treatment of diphtheroid endocarditis. vancomycin is used in combination with rifampicin, an aminoglycoside, or both in early onset prosthetic valve endocarditis caused by staph. epidermidis or diphtheroids. the effectiveness of vancomycin has been documented in other infections due to staphylococci including osteomyelitis, pneumonia, septicaemia and, skin and skin structure infections. when staphylococcal infections are localised and purulent, antibiotics are used as adjuncts to appropriate surgical measures. specimens for bacteriological cultures should be obtained in order to isolate and identify causative organisms and to determine their susceptibilities to vancomycin. vancomycin should be administered orally for the treatment of staphylococcal enterocolitis and antibiotic associated pseudomembranous colitis (produced by c. difficile). parenteral administration of vancomycin alone is inappropriate for this indication. vancomycin is not effective by the oral route for other types of infections. for oral administration the parenteral formulation may be used. some systemic absorption may occur following oral administration in patients with pseudomembranous colitis.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - vancomycin hydrochloride, quantity: 512.5 mg (equivalent: vancomycin, qty 500 mg) - injection, powder for - excipient ingredients: hydrochloric acid; sodium hydroxide - vancomycin hydrochloride for intravenous infusion is indicated for potentially life threatening infections which cannot be treated with another effective, less toxic antimicrobial medicine, including the penicillins and cephalosporins. vancomycin is useful in therapy of severe staphylococcal (including methicillin-resistant staphylococcal) infections in patients who cannot receive or who have failed to respond to the penicillins and cephalosporins or who have infections with staphylococci that are resistant to other antibiotics. once sensitivity data are available, therapy should be adjusted accordingly. vancomycin is effective alone or in combination with an aminoglycoside for endocarditis caused by strep. viridans or strep. bovis. for endocarditis caused by enterococci (eg enterococcus faecalis), vancomycin is effective only in combination with an aminoglycoside. vancomycin is effective for the treatment of diphtheroid endocarditis. vancomycin is used in combination with rifampicin, an aminoglycoside, or both in early onset prosthetic valve endocarditis caused by staph. epidermidis or diphtheroids. the effectiveness of vancomycin has been documented in other infections due to staphylococci including osteomyelitis, pneumonia, septicaemia and, skin and skin structure infections. when staphylococcal infections are localised and purulent, antibiotics are used as adjuncts to appropriate surgical measures. specimens for bacteriological cultures should be obtained in order to isolate and identify causative organisms and to determine their susceptibilities to vancomycin. vancomycin should be administered orally for the treatment of staphylococcal enterocolitis and antibiotic associated pseudomembranous colitis (produced by c. difficile). parenteral administration of vancomycin alone is inappropriate for this indication. vancomycin is not effective by the oral route for other types of infections. for oral administration the parenteral formulation may be used. some systemic absorption may occur following oral administration in patients with pseudomembranous colitis.

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

energique, inc. - horse chestnut (unii: 3c18l6rjaz) (horse chestnut - unii:3c18l6rjaz), harpagophytum procumbens root (unii: 1oym338e89) (harpagophytum procumbens root - unii:1oym338e89), phytolacca americana root (unii: 11e6vi8veg) (phytolacca americana root - unii:11e6vi8veg), ruta graveolens flowering top (unii: n94c2u587s) (ruta graveolens flowering top - unii:n94c2u587s), sus scrofa cartilage (unii: 73ecw5wg2f) (sus scrofa cartilage - unii:73ecw5wg2f), sus scrofa intervertebral disc (unii: oj17o2wtsm) (sus scrofa - may temporarily relieve minor back pain, stiffness, numbness or tingling.** **claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated. may temporarily relieve minor back pain, stiffness, numbness or tingling.** **claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

nutritional specialties, inc. - sus scrofa cartilage (unii: 73ecw5wg2f) (sus scrofa cartilage - unii:73ecw5wg2f), sus scrofa cerebellum (unii: 49ngk53tpq) (sus scrofa cerebellum - unii:49ngk53tpq), sus scrofa intervertebral disc (unii: oj17o2wtsm) (sus scrofa intervertebral disc - unii:oj17o2wtsm), sus scrofa bone marrow (unii: vp2cn2g7y8) (sus scrofa bone marrow - unii:vp2cn2g7y8) - provides specific sarcode support for the spinal nerves.† †claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated. provides specific sarcode support for the spinal nerves.† †claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

deseret biologicals, inc. - antimony trisulfide (unii: f79059a38u) (antimony trisulfide - unii:f79059a38u), arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), bismuth subnitrate (unii: h19j064ba5) (bismuth cation - unii:zs9cd1i8ye), sodium borate (unii: 91mbz8h3qo) (borate ion - unii:44oae30d22), bryonia alba root (unii: t7j046yi2b) (bryonia alba root - unii:t7j046yi2b), tribasic calcium phosphate (unii: 91d9gv0z28) (calcium cation - unii:2m83c4r6zb), candida albicans (unii: 4d7g21hdbc) (candida albicans - unii:4d7g21hdbc), matricaria chamomilla whole (unii: g0r4ubi2zz) (matricaria chamomilla - unii:g0r4ubi2zz), cinchona officinalis bark (unii: s003a158sb) (cinchona officinalis bark - unii:s003a158sb), sus scrofa intervertebral disc (unii: oj17o2wtsm) (sus scrofa intervertebral disc - unii:oj17o2wtsm), herring sperm dna (unii: 51fi676n6f) (herring sperm dna - unii:51fi676n6f), echinacea purpurea whole (unii: qi7g114y98) (echinacea purpurea - unii:qi7g114y98), strychnos ignatii seed (unii: 1nm3m2487k) (strychnos ignatii seed - unii:1nm3m2487k), juglans cinerea branch bark/root bark (unii: 48fz1bho18) (juglans cinerea branch bark/root bark - unii:48fz1bho18), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838), mercurius solubilis (unii: 324y4038g2) (mercurius solubilis - unii:324y4038g2), hydrochloric acid (unii: qtt17582cb) (hydrochloric acid - unii:qtt17582cb), nutmeg (unii: aee24m3mq9) (nutmeg - unii:aee24m3mq9), sus scrofa oral mucosa (unii: dup6w562bm) (sus scrofa oral mucosa - unii:dup6w562bm), oxygen (unii: s88tt14065) (oxygen - unii:s88tt14065), sambucus nigra flowering top (unii: ct03bsa18u) (sambucus nigra flowering top - unii:ct03bsa18u), sepia officinalis juice (unii: qdl83wn8c2) (sepia officinalis juice - unii:qdl83wn8c2), staphylococcus aureus (unii: o478wx4004) (staphylococcus aureus - unii:o478wx4004), streptococcus mutans (unii: 5c7j33mjj1) (streptococcus mutans - unii:5c7j33mjj1) - antimonium crudum – mouth support, arsenicum album – dental support, bismuthum subnitricum – pain in ears, borax – dry mouth, bryonia (alba) – eruption on tongue, calcarea phosphorica – dental issues, candida albicans – eruption on cheeks, chamomilla – teeth sensitivity, cinchona officinalis – mouth support, discus intervertebralis suis – dry mouth, dna – mouth support, echinacea purpurea – mouth support, ignatia amara – teeth sensitivity, juglans cinerea – pain in ears, kali muriaticum – eruption on tongue, magnesia muriatica – dental support, mercurius solubilis – teeth sensitivity, muriaticum acidum – dry mouth, nux moschata – dry mouth, oral mucosa (suis) – mouth support, oxygenium – eruption on tongue, sambucus nigra – dry mouth, sepia – teeth sensitivity, staphylococcus aureus – mouth support, streptococcus mutans – mouth support • for the temporary relief of symptoms including: • mouth support • teeth sensitivity • dental issues • dental support • pain in ears • eruption on tongue • eruption on cheeks • dry mouth these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

discus dental australia pty limited -

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

discus dental australia pty limited -

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

discus dental australia pty limited -

أستراليا - الإنجليزية - Department of Health (Therapeutic Goods Administration)

discus dental australia pty limited -